Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TransMedics Group, Inc. | Director | Common Stock | 173K | $27.7M | $159.96 | Aug 8, 2024 | By the James R. Tobin 2012 Trust |
TransMedics Group, Inc. | Director | Common Stock | 1.93K | $308K | $159.96 | Aug 8, 2024 | Direct |
Lyra Therapeutics, Inc. | Director | Stock Option | 30K | Jun 13, 2024 | Direct | ||
GLOBUS MEDICAL INC | Director | Stock Option (Right to Buy Class A Common Stock) | 15K | Jan 26, 2024 | Direct | ||
TransMedics Group, Inc. | Director | Stock Option (Right to Buy) | 1.15K | May 23, 2024 | Direct |